Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DespaTIL Study
NCT07074106Phase 2Recruiting
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Oct 2025
- Primary completion
- Jul 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in triple-negative breast cancer (TNBC), sponsored by Instituto D’Or de Pesquisa e Ensino. Started Oct 2025; status: recruiting.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT07074106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074106.